Skopos Labs, Inc. Astrazeneca PLC Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Skopos Labs, Inc. holds 14,707 shares of AZN stock, worth $1.06 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
14,707
Previous 1,775
728.56%
Holding current value
$1.06 Million
Previous $116,000
831.03%
% of portfolio
0.24%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,429Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.11 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.29 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.25 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...